The host-immune response to SARS-CoV-2 infection varies. Some individuals have a strong immune response, resulting in a cytokine storm and debilitating physical symptoms. Others experience only mild symptoms, if any at all.
Understanding the host-immune response to SARS-CoV-2 is important for vaccine development efforts, interpreting disease pathogenesis, and calibrating future pandemic control measures. This webinar will explore recent discoveries about the way the immune system responds to SARS-CoV-2 infection.
The recent global outbreak of the 2019 coronavirus disease, COVID-19 caused by the novel severe acute respiratory syndrome coronavirus, SARS-CoV-2, and its rapid spread across the globe has spurred an increased focus on deeper understanding of virus biology and effective development of new vaccines. Surveillance of pathogens and reliable testing methods are additional main pillars (strategies) of stopping the spread of pandemics to vulnerable populations.
We, at Sartorius continue to support and simplify the virology and vaccine research and development as well as environmental monitoring efforts with advanced cell and protein analysis platforms and downstream research tools enabling vaccine developers to gain critical new information, with confidence, as quickly as possible.
Watch the full webinar: [ Ссылка ]
Learn about our solutions: [ Ссылка ]
